Furthermore, a prespecified subgroup analysis of HF individuals from the SELECT trial evaluating the effects of semaglutide on cardiovascular outcomes in people with overweight or obesity, which included 2,273 HFpEF and 1,347 HFrEF patients, showed that the therapy was associated with a reduction in the HF composite outcome (cardiovascular death or HF hospitalisation/emergency visit) across LVEF, suggesting that GLP-1 RAs may improve outcomes at least in obese HF patients regardless of diabetes status
Yang and Stockwell, 2016
Table of Contents How to Store Retatrutide Once It Has Been Reconstituted Reconstituted retatrutide must be stored strictly according to the IMP label or trial pharmacy manual
Whether its the shortage, side effects, lack of insurance, or high out-of-pocket costs that prompt patients to stop taking GLP-1 drugs like Ozempic, they all face the same issue: how to maintain the results they got from the drug after they stop taking it, says Robert Kushner, MD, a professor and the director of the Center for Lifestyle Medicine at Northwestern University Feinberg School of Medicine in Chicago
Can I use GHK-Cu while pregnant or breastfeeding
